Literature DB >> 26790995

Ubiquitin-Related Roles of β-Arrestins in Endocytic Trafficking and Signal Transduction.

Pierre-Yves Jean-Charles1, Vishwaesh Rajiv1, Sudha K Shenoy1,2.   

Abstract

The non-visual arrestins, β-arrestin1, and β-arrestin2 were originally identified as proteins that bind to seven-transmembrane receptors (7TMRs, also called G protein-coupled receptors, GPCRs) and block heterotrimeric G protein activation, thus leading to desensitization of transmembrane signaling. However, as subsequent discoveries have continually demonstrated, their functionality is not constrained to desensitization. They are now recognized for their critical roles in mediating intracellular trafficking of 7TMRs, growth factor receptors, ion transporters, ion channels, nuclear receptors, and non-receptor proteins. Additionally, they function as crucial mediators of ubiquitination of 7TMRs as well as other receptors and non-receptor proteins. Recently, emerging studies suggest that a class of proteins with predicted structural features of β-arrestins regulate substrate ubiquitination in yeast and higher mammals, lending support to the idea that the adaptor role of β-arrestins in protein ubiquitination is evolutionarily conserved. β-arrestins also function as scaffolds for kinases and transduce signals from 7TMRs through pathways that do not require G protein activation. Remarkably, the endocytic and scaffolding functions of β-arrestin are intertwined with its ubiquitination status; the dynamic and site specific ubiquitination on β-arrestin plays a critical role in stabilizing β-arrestin-7TMR association and the formation of signalosomes. This review summarizes the current findings on ubiquitin-dependent regulation of 7TMRs as well as β-arrestins and the potential role of reversible ubiquitination as a "biological switch" in signal transduction. J. Cell. Physiol. 231: 2071-2080, 2016.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26790995     DOI: 10.1002/jcp.25317

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  16 in total

1.  β-Arrestin 1 has an essential role in neurokinin-1 receptor-mediated glioblastoma cell proliferation and G2/M phase transition.

Authors:  Yi-Xin Zhang; Xiao-Fang Li; Guo-Qiang Yuan; Hui Hu; Xiao-Yun Song; Jing-Yi Li; Xiao-Kang Miao; Tian-Xiong Zhou; Wen-Le Yang; Xiao-Wei Zhang; Ling-Yun Mou; Rui Wang
Journal:  J Biol Chem       Date:  2017-03-24       Impact factor: 5.157

Review 2.  Post-translational Modifications of Opioid Receptors.

Authors:  Mariana Lemos Duarte; Lakshmi A Devi
Journal:  Trends Neurosci       Date:  2020-04-16       Impact factor: 13.837

3.  Dopamine D2 receptor restricts astrocytic NLRP3 inflammasome activation via enhancing the interaction of β-arrestin2 and NLRP3.

Authors:  Jialei Zhu; Zhaoli Hu; Xiaojuan Han; Dongshuo Wang; Qingling Jiang; Jianhua Ding; Ming Xiao; Cong Wang; Ming Lu; Gang Hu
Journal:  Cell Death Differ       Date:  2018-05-21       Impact factor: 15.828

4.  The HECT ubiquitin E3 ligase Smurf2 degrades μ-opioid receptor 1 in the ubiquitin-proteasome system in lung epithelial cells.

Authors:  Su Dong; Jia Liu; Lian Li; Heather Wang; Haichun Ma; Yutong Zhao; Jing Zhao
Journal:  Am J Physiol Cell Physiol       Date:  2019-02-13       Impact factor: 4.249

Review 5.  G Protein-Coupled Receptor Signaling Through β-Arrestin-Dependent Mechanisms.

Authors:  Pierre-Yves Jean-Charles; Suneet Kaur; Sudha K Shenoy
Journal:  J Cardiovasc Pharmacol       Date:  2017-09       Impact factor: 3.105

6.  The α-Arrestin ARRDC3 Regulates the Endosomal Residence Time and Intracellular Signaling of the β2-Adrenergic Receptor.

Authors:  Xufan Tian; Roshanak Irannejad; Shanna L Bowman; Yang Du; Manojkumar A Puthenveedu; Mark von Zastrow; Jeffrey L Benovic
Journal:  J Biol Chem       Date:  2016-05-11       Impact factor: 5.157

7.  Mdm2 regulates cardiac contractility by inhibiting GRK2-mediated desensitization of β-adrenergic receptor signaling.

Authors:  Pierre-Yves Jean-Charles; Samuel Mon-Wei Yu; Dennis Abraham; Reddy Peera Kommaddi; Lan Mao; Ryan T Strachan; Zhu-Shan Zhang; Dawn E Bowles; Leigh Brian; Jonathan A Stiber; Stephen N Jones; Walter J Koch; Howard A Rockman; Sudha K Shenoy
Journal:  JCI Insight       Date:  2017-09-07

Review 8.  β-arrestin1 at the cross-road of endothelin-1 signaling in cancer.

Authors:  Laura Rosanò; Anna Bagnato
Journal:  J Exp Clin Cancer Res       Date:  2016-07-29

9.  Class B β-arrestin2-dependent CCR5 signalosome retention with natural antibodies to CCR5.

Authors:  Assunta Venuti; Claudia Pastori; Rosamaria Pennisi; Agostino Riva; Maria Teresa Sciortino; Lucia Lopalco
Journal:  Sci Rep       Date:  2016-12-23       Impact factor: 4.379

10.  Manifold roles of β-arrestins in GPCR signaling elucidated with siRNA and CRISPR/Cas9.

Authors:  Louis M Luttrell; Jialu Wang; Bianca Plouffe; Jeffrey S Smith; Lama Yamani; Suneet Kaur; Pierre-Yves Jean-Charles; Christophe Gauthier; Mi-Hye Lee; Biswaranjan Pani; Jihee Kim; Seungkirl Ahn; Sudarshan Rajagopal; Eric Reiter; Michel Bouvier; Sudha K Shenoy; Stéphane A Laporte; Howard A Rockman; Robert J Lefkowitz
Journal:  Sci Signal       Date:  2018-09-25       Impact factor: 9.517

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.